Strong DiviTum TKa Results Published in JCO Precision Oncology

UPPSALA, SE / ACCESS Newswire / January 27, 2026 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II), a leader in blood-based cancer monitoring, today announced that DiviTum TKa data from the Ciclib trial at Roswell Park have been …